Julie's brand new Big Gorgeous Goals: Official Workbook can be ordered now! Grab your copy.
Dr. Joan Fallon shares her journey from clinical practice to founding Curemark, a biotech company developing novel therapies for Autism based on her discovery of enzyme deficiencies in children with the condition. Her innovative approach challenges traditional pharmaceutical development by addressing the physiological root causes of Autism rather than just treating symptoms.
Dr. Joan Fallon, Founder and CEO of Curemark, is a visionary scientist dedicated to improving the health and well-being of children globally. Under her leadership, Curemark has developed novel therapies for diseases with limited treatment options, including a Phase III clinical program for Autism and research on Parkinson’s Disease, schizophrenia, and addiction. The company’s first drug, CM-AT, targeting autism, has earned Fast Track status from the FDA. Dr. Fallon holds over 400 patents, has authored numerous scholarly articles, and is a sought-after lecturer. Recognized as one of Goldman Sachs' Top 100 Most Intriguing Entrepreneurs of 2020 and a recipient of the EY Entrepreneur Of The Year Award in 2017, she also published her first book, Goodbye, Status Quo: Reimagining the Landscape of Innovation, in 2022. A respected business leader, doctor, and academic, Joan is passionate about sharing her insights on entrepreneurship and innovation.
You can connect with Dr. Joan Fallon on LinkedIn. You can also learn more about Curemark on their website.
You can connect with Julie on LinkedIn or Instagram.
Find Julie's writing at her blog or by ordering her book Big Gorgeous Goals and the brand new official companion workbook!
What did you think of this conversation? We'd love if you'd rate or review our show!
